Exact Mass: 308.9701858
Exact Mass Matches: 308.9701858
Found 69 metabolites which its exact mass value is equals to given mass value 308.9701858
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Lamivudine-monophosphate
C8H12N3O6PS (309.01844220000004)
Lamivudine-monophosphate is a metabolite of lamivudine. Lamivudine (2,3-dideoxy-3-thiacytidine, commonly called 3TC) is a potent nucleoside analog reverse transcriptase inhibitor (nRTI). It is marketed by GlaxoSmithKline with the brand names Zeffix, Heptovir, Epivir, and Epivir-HBV. Lamivudine has been used for treatment of chronic hepatitis B at a lower dose than for treatment of HIV. It improves the seroconversion of e-antigen positive hepatitis B and also improves histology staging of the liver. (Wikipedia)
PRZ_M310
C12H14Cl3NO2 (309.00900740000003)
CONFIDENCE Transformation product, tentative ID (Level 2b); INTERNAL_ID 2015
5-BROMO-2-CHLORO-N-PHENYLBENZAMIDE
C13H9BrClNO (308.95559940000004)
ethyl 6-bromo-8-methyl-4-oxo-1H-quinoline-3-carboxylate
C13H12BrNO3 (309.00005020000003)
5-(CHLOROMETHYL)-2-(2-FLUORO-4-(TRIFLUOROMETHYL)PHENYL)-4-METHYLTHIAZOLE
N-(4-Bromophenyl)-4,4,4-trifluoro-3-oxobutanamide
C10H7BrF3NO2 (308.96122180000003)
3-Chloro-4-[1,1,2-trifluoro-2-(trifluoromethoxy)ethoxy]benzenamine
2-[(4-BROMOPHENYL)THIO]NICOTINIC ACID
C12H8BrNO2S (308.94590880000004)
2-Bromo-N-(4-chlorophenyl)benzamide
C13H9BrClNO (308.95559940000004)
2-chloro-10-(3-chloropropyl)-10H-phenothiazine
C15H13Cl2NS (309.01457180000006)
4-BROMO-N-(FURAN-2-YLMETHYL)-3-METHOXYBENZAMIDE
C13H12BrNO3 (309.00005020000003)
Ethyl1-(5-bromopyridin-2-yl)-5-methylpyrazole-4-carboxylate
5-Bromo-1-(4-methoxybenzyl)-1H-pyrrole-2-carboxylic acid
C13H12BrNO3 (309.00005020000003)
2,5-Cyclohexadien-1-one,4-[[4-(acetyloxy)phenyl]imino]-2,6-dichloro-
Ethanone,2-chloro-1-(2-chloro-10H-phenothiazin-10-yl)-
ethyl 4-bromo-6-methoxyquinoline-3-carboxylate
C13H12BrNO3 (309.00005020000003)
2-amino-5-bromo-2-chlorobenzophenone
C13H9BrClNO (308.95559940000004)
3-(3-chlorophenyl)-4-cyano-5-methylsulfanylthiophene-2-carboxylic acid
3-(4-CHLOROPHENYL)-4-CYANO-5-(METHYLTHIO)THIOPHENE-2-CARBOXYLIC ACID
ETHYL5-AMINO-1-(4-BROMOPHENYL)-1H-PYRAZOLE-4-CARBOXYLATE
METHYL 3-AMINO-4-(ISOPROPYLSULFONYL)-5-(METHYLTHIO)THIOPHENE- 2-CARBOXYLATE
[2-(3-bromo-phenyl)-ethyl]-(4-chloro-phenyl)-amine
C14H13BrClN (308.9919828000001)
6-Chloro-4-hydroxy-2-methyl-2H-thieno[2,3-e]-1,2-thiazine-3-carboxylic acid methyl ester 1,1-dioxide
ETHYL 5-AMINO-1-(2-BROMOPHENYL)-1H-PYRAZOLE-4-CARBOXYLATE
4-Bromo-N-(4-chlorophenyl)benzamide
C13H9BrClNO (308.95559940000004)
5-chloro-N-(2,4-difluorophenyl)thiophene-2-sulfonamide
ethyl 4-bromo-8-methoxyquinoline-3-carboxylate
C13H12BrNO3 (309.00005020000003)
4-ISOXAZOLECARBOXYLIC ACID, 5-(4-BROMOPHENYL)-3-METHYL-, ETHYL ESTER
C13H12BrNO3 (309.00005020000003)
Ethyl 3-bromo-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine-2-carboxylate hydrochloride
5-bromo-N-cyclopentyl-2-(trifluoromethyl)pyrimidin-4-amine
4-bromo-N-(tert-butyl)-2-fluorobenzenesulfonamide
C10H13BrFNO2S (308.98343500000004)
5-bromo-n-(2-hydroxyethyl)-2-methoxybenzenesulfonamide
2-(5-bromo-4-oxopentyl)isoindole-1,3-dione
C13H12BrNO3 (309.00005020000003)
4-[(4-CHLOROPHENYL)SULFANYL]-3-NITROBENZENECARBOXYLIC ACID
C13H8ClNO4S (308.98625580000004)
4-ISOXAZOLECARBOXYLIC ACID, 3-(4-BROMOPHENYL)-5-METHYL-, ETHYL ESTER
C13H12BrNO3 (309.00005020000003)
Anagrelide hydrochloride monohydrate
C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent
5-Hydroxydiclofenac quinone imine
A quinone imine that is a metabolite of diclofenac arising from 5-hydroxylation followed by oxidation.
6-Amino-5-[(4-chlorophenyl)sulfonyl]-2-hydroxynicotinonitrile
C12H8ClN3O3S (308.99748880000004)
N-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]formamide
C12H14Cl3NO2 (309.00900740000003)
N-[(E)-(5-bromothiophen-2-yl)methylideneamino]pyridine-2-carboxamide
C11H8BrN3OS (308.95714180000004)
4-hydroxydiclofenac quinone imine
A quinone imine that is a metabolite of diclofenac arising from 4-hydroxylation followed by oxidation.